A New Trend In Marijuana Has Investors Looking At These Pot Stocks

CORAL GABLES, FL / ACCESSWIRE / November 21, 2018 / Many marijuana stocks have seen a rally in the stock market this month. This is even as the broader markets for things like tech and even oil took a hit to prices. An increasing number of companies have been focused on getting a foothold within the industry. Most recently it has been companies within the beverage market who have taken a more active approach.

Constellation Brands (STZ) broke the ice last year and further this year with its billion dollar investments into the space. "We believe this represents a unique growth opportunity and through our partnership with Canopy, we are well-positioned to take a leadership role as this market continues to evolve," said Constellation CEO Rob Sands. "One hallmark of Constellation's success over the years is our ability to stay on the forefront of emerging consumer trends and that will continue to fuel our long-term success."

With investors and traditional businesses latching onto marijuana stocks, there are 4 stocks to watch heading into the holidays including ICC International Cannabis Corp. (KNHBF) ( WRLD ), Cronos Group (CRON), Innovative Industrial Properties (IIPR) and Advantis Corp. (OTC PINK: ADVT).

ICC International Cannabis Corp. (KNHBF) (WRLD) recently announced that the company that it has entered into a definitive agreement to acquire 100per cent of Enigma Unipessoal Lda. Enigma controls one of the first hemp licenses to be issued in Portugal, which permits the cultivation, processing and import/export of hemp-derived products. Enigma successfully harvested and extracted its first hemp crop in 2015, and has become a notable importer of proprietary hemp seeds.

This license authorizes International Cannabis to cultivate hemp on 400 acres of fertile agricultural land located in the Castelo Branco region of Portugal. The Company's Portuguese hemp operations are estimated to yield 45,000 kg of finished, extracted pure cannabidiol isolate product per annum, and a full operating team and infrastructureis in place.

Eugene Beukman, CEO and a director of ICC International Cannabis Corp. (KNHBF) (WRLD) stated, "International Cannabis is progressing towards a full spectrum cannabis license in Portugal, which it is hopeful to achieve before the end of Q1 2019. The Company considers the addition of this hemp licence as the first step towards developing a material cultivation presence in Portugal."

In addition, the company announced that it has also entered into a definitive agreement to acquire 100 per-cent of Green Gene Research Inc. Green Gene boasts 17 years of experience in the fields of Cannabis research, testing, cultivation, as well as the optimization of proprietary seeds and strains.

For more information on ICC International Cannabis Corp. (KNHBF) (WRLD) Click Here

Cronos Group (CRON) has been another marijuana stock reversing its bearish trend. Shares of the cannabis company traded as high as $8.75 on Wednesday ahead of the holidays in the US. Cronos Group operates two wholly-owned Canadian license holders: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia.

In October, the Company announced it had entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology ("Technion") to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and wound healing.

The company recently announced its 3rd quarter results this month. The company reported increased revenues of 186% and kilograms sold were up 213% year-over-year. Cronos also announced a landmark partnership with Ginkgo Bioworks to produce cultured cannabinoids as well as a launched a mainstream recreational brand called Spinachâ„¢.

"We are encouraged with our third quarter results, which reflect the meaningful progress we are making on our strategic initiatives. In the quarter, we announced a number of landmark partnerships to expand our reach beyond the flower and beyond Canada and launched our second differentiated recreational cannabis brand," said Mike Gorenstein, CEO of Cronos Group.